Legal & General Group’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-444
Closed -$3.82K 3490
2025
Q1
$3.82K Hold
444
﹤0.01% 3312
2024
Q4
$15.9K Hold
444
﹤0.01% 3110
2024
Q3
$21K Hold
444
﹤0.01% 3028
2024
Q2
$22.3K Hold
444
﹤0.01% 2974
2024
Q1
$49.7K Sell
444
-737
-62% -$73.3K ﹤0.01% 2779
2023
Q4
$68.5K Sell
1,181
-945
-44% -$38K ﹤0.01% 2778
2023
Q3
$67.5K Sell
2,126
-787
-27% -$37.4K ﹤0.01% 2851
2023
Q2
$240K Buy
2,913
+1,455
+100% +$213K ﹤0.01% 2696
2023
Q1
$150K Buy
1,458
+50
+4% +$7.02K ﹤0.01% 2672
2022
Q4
$206K Buy
1,408
+53
+4% +$8.96K ﹤0.01% 2598
2022
Q3
$229K Buy
1,355
+93
+7% +$15.1K ﹤0.01% 2574
2022
Q2
$145K Buy
1,262
+250
+25% +$23.5K ﹤0.01% 2749
2022
Q1
$101K Buy
1,012
+7
+0.7% +$818 ﹤0.01% 2864
2021
Q4
$156K Hold
1,005
﹤0.01% 2800
2021
Q3
$236K Buy
1,005
+445
+79% +$130K ﹤0.01% 2634
2021
Q2
$190K Buy
560
+36
+7% +$13.6K ﹤0.01% 2546
2021
Q1
$212K Sell
524
-20
-4% -$9.7K ﹤0.01% 2445
2020
Q4
$362K Sell
544
-4
-0.7% -$2.22K ﹤0.01% 2318
2020
Q3
$255K Sell
548
-45
-8% -$22.7K ﹤0.01% 2319
2020
Q2
$347K Buy
593
+404
+214% +$138K ﹤0.01% 2253
2020
Q1
$27K Sell
189
-51
-21% -$8.91K ﹤0.01% 2801
2019
Q4
$34K Hold
240
﹤0.01% 2996
2019
Q3
$9K Hold
240
﹤0.01% 3278
2019
Q2
$24K Buy
240
+163
+212% +$19.2K ﹤0.01% 3128
2019
Q1
$10K Hold
77
﹤0.01% 3247
2018
Q4
$8K Hold
77
﹤0.01% 3287
2018
Q3
$19K Hold
77
﹤0.01% 3221
2018
Q2
$35K Sell
77
-1
-1% -$439 ﹤0.01% 2931
2018
Q1
$31K Buy
78
+50
+179% +$19.7K ﹤0.01% 2965
2017
Q4
$12K Hold
28
﹤0.01% 3219
2017
Q3
$12K Buy
+28
New +$11K ﹤0.01% 3259

Other funds holding MRSN